Showing results (91-100 of 137) with videos related to
Sort By:
Pageof 14
Alimentary Pharmacology & Therapeutics|March 16, 2019
The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter studyMasanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, et al.Journal of Gastroenterology and Hepatology|August 26, 2018
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter studyMasanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 6, 2026
Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-BevacizumabToshinori Toyota, Satoshi Narahara, Haruki Uojima, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 11, 2021
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Haruki Uojima, Nobuhiro Hattori, et al.Hepatology Communications|March 28, 2022
Mac-2-binding protein glycan isomer predicts all malignancies after sustained virological response in chronic hepatitis CKazuhito Kawata, Masanori Atsukawa, Kazuyoshi Ohta, et al.Journal of Medical Virology|March 6, 2026
Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus InfectionHidenori Toyoda, Akito Nozaki, Atsushi Hiraoka, et al.Cancers|January 30, 2020
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Haruki Uojima, Kazushi Numata, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 11, 2024
Evaluation of the associations of interlukin-7 genetic variants with toxicity and efficacy of immune checkpoint inhibitors: A replication study of a Japanese population, based on the findings of a European genome-wide association studyHideaki Miyamoto, Yasuteru Kondo, Ei Itobayashi, et al.Journal of Gastroenterology|April 16, 2024
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammationHaruki Uojima, Kazumi Yamasaki, Masaya Sugiyama, et al.Clinical and Experimental Gastroenterology|October 16, 2020
Safety and Efficacy of Lenvatinib Treatment in Child-Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter AnalysisKatsuaki Ogushi, Makoto Chuma, Haruki Uojima, et al.Pageof 14